tradingkey.logo

Pasithea Therapeutics Says Positive PAS-004 Tablet Pharmacokinetic Data In Ongoing Phase 1/1B Trial In Adult NF1 Patients

ReutersNov 21, 2025 7:18 PM

- Pasithea Therapeutics Corp KTTA.O:

  • PASITHEA THERAPEUTICS ANNOUNCES POSITIVE PAS-004 TABLET PHARMACOKINETIC (PK) DATA IN ONGOING PHASE 1/1B TRIAL IN ADULT NF1 PATIENTS

  • PASITHEA THERAPEUTICS CORP - TABLET PK EXPOSURE INCREASES PROPORTIONALLY WITH DOSE

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI